Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients
Primary Purpose
Critical Illness
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Enteral Formula With Fructose
Enteral Formula Without Fructose
Sponsored by
About this trial
This is an interventional supportive care trial for Critical Illness focused on measuring Hyperglycemia, Fructose, Diabetes mellitus, Enteral Nutrition, Glycemic Variability
Eligibility Criteria
Inclusion Criteria:
- Critical Illness
- Exclusive enteral diet
- Enteral diet with full nutritional value
- Hyperglycemia ≥180 mg / dl
Exclusion Criteria:
- Oral feeding
- NPT (Total or Partial Parenteral Nutrition)
- Patient without indication of use of study diets
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Diet 1
Diet 2
Arm Description
Low-carbohydrate Enteral Formula With Fructose
Low-carbohydrate Enteral Formula Without Fructose
Outcomes
Primary Outcome Measures
Glycemic Variability
To evaluate the glycemic oscillation during the use of enteral feedings
Secondary Outcome Measures
Full Information
NCT ID
NCT03003507
First Posted
December 22, 2016
Last Updated
December 27, 2016
Sponsor
Hospital Moinhos de Vento
1. Study Identification
Unique Protocol Identification Number
NCT03003507
Brief Title
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients
Official Title
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients: A Cross-over Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
April 2011 (Actual)
Study Completion Date
April 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Moinhos de Vento
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Hyperglycemia is a known risk factor for mortality in critically ill patients. Most of these patients receive enteral feeding. There is controversy about ideal carbohydrate composition of these diets. The aim of this study was to compare an enteral formula with the same proportion of carbohydrates with and without fructose on blood glucose levels.
Detailed Description
Randomized, cross-over, controlled, double-blind clinical trial without washout. Adult patients admitted to the ICU who presented capillary glycemia values> 180mg / dl with a full and exclusive enteral diet. They were randomized and observed for 4 days (2 days with each diet: with / without fructose). Capillary glycemia was measured 4 / 4h.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
Hyperglycemia, Fructose, Diabetes mellitus, Enteral Nutrition, Glycemic Variability
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Diet 1
Arm Type
Active Comparator
Arm Description
Low-carbohydrate Enteral Formula With Fructose
Arm Title
Diet 2
Arm Type
Active Comparator
Arm Description
Low-carbohydrate Enteral Formula Without Fructose
Intervention Type
Dietary Supplement
Intervention Name(s)
Enteral Formula With Fructose
Intervention Description
Low-carbohydrate Enteral Formula With Fructose
Intervention Type
Dietary Supplement
Intervention Name(s)
Enteral Formula Without Fructose
Intervention Description
Low-carbohydrate Enteral Formula Without Fructose
Primary Outcome Measure Information:
Title
Glycemic Variability
Description
To evaluate the glycemic oscillation during the use of enteral feedings
Time Frame
four days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Critical Illness
Exclusive enteral diet
Enteral diet with full nutritional value
Hyperglycemia ≥180 mg / dl
Exclusion Criteria:
Oral feeding
NPT (Total or Partial Parenteral Nutrition)
Patient without indication of use of study diets
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Glycemic Index Variation During Low-carbohydrate Enteral Formula With and Without Fructose in Critically Ill Patients
We'll reach out to this number within 24 hrs